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Association with alcohol dependence disorder and
reported drinking consequences
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Figure 1
RSOD frequency transitions from baseline (BL) to follow-up (FU)
(N = 5,196).
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Prevalence of alcohol dependence and alcohol use
consequences
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Associations between RSOD at baseline, alcohol
dependence and reported drinking consequences at
follow-up
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Table 1: Sample’s characteristics.
Variable Mean ± standard deviation Participants Loss to follow-up
N1 % N %2
Age at baseline 20.00 ± 1.23
RSOD frequency at baseline 5,968 772 12.9
Alcohol abstainers 483 8.1 89 18.4
Non-RSO drinking 781 13.1 90 11.5
Less than once a month 1,958 32.8 225 11.5
Every month 1,397 23.4 167 12.0
Every week 1,277 21.4 186 14.6
Every day or nearly 72 1.2 15 20.8
Smoking at baseline 2,840 47.6 455 15.8
Financial situation of the parents
Very much less well-off 143 2.4 27 18.9
Much less well-off 565 9.4 60 10.6
Less well-off 1919 32.0 208 10.8
About the same 2473 41.3 328 13.3
Better-off 661 11.0 103 15.6
Much better-off 154 2.6 23 14.9
Very much better-off 47 0.8 11 23.4
Missing 28 0.5 7 25.0
Age at follow-up 21.26 ± 1.23
RSOD frequency at follow-up 5,196 87.1
Alcohol abstainers 386 7.4
Non-RSO drinking 700 13.5
Less than once a month 1,829 35.2
Every month 1,222 23.5
Every week 1,018 19.6
Every day or nearly 41 0.8
Smoking at baseline 2,385 45.5
Alcohol dependence at follow-up 421 8.1
Drinking consequences at follow-up
Blackout 1,440 27.7
Later-regretted unspecified misconduct 1,234 23.7
Unplanned sexual intercourse 642 12.4
Unsafe sexual intercourse 384 7.4
Accident or injury 504 9.7
Conflict with the police 201 3.9
Fight or serious argument 503 9.7
Damage to somebody else's property 390 7.5
1 Sample sizes after list wise deletion.
2 This column describes intragroup drop out rate.
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Table 3: Associations of RSOD frequency with alcohol dependence and drinking consequences.
Outcome RSOD frequency at baseline N Prevalence OR1 95% CI
Alcohol abstainers 386 2.8% 9.42** 2.27 39.11
Non-RSO drinking 700 1.3% 1
Less than once a month 1,829 4.2% 3.92* 1.21 12.68
Every month 1,222 7.9% 6.66*** 2.01 21.35
Every week 1,018 19.9% 18.40*** 5.81 58.30
Alcohol dependence disorder
Every day or nearly 41 21.1% 22.40** 5.82 86.23
Alcohol abstainers 386 16.2% 1.56 0.69 3.56
Non-RSO drinking 700 8.9% 1
Less than once a month 1,829 21.2% 2.39*** 1.54 3.69
Every month 1,222 35.3% 4.55*** 2.95 7.01
Every week 1,018 50.2% 8.08*** 5.24 12.45
Blackout
Every day or nearly 41 49.1% 6.90*** 3.28 14.53
Alcohol abstainers 386 9.5% 1.27 0.49 3.32
Non-RSO drinking 700 7.9% 1
Less than once a month 1,829 18.2% 2.52*** 1.57 4.06
Every month 1,222 29.5% 4.49*** 2.80 7.21
Every week 1,018 44.0% 8.57*** 5.35 13.73
Later-regretted misconduct
Every day or nearly 41 45.6% 8.54*** 3.96 18.42
Alcohol abstainers 386 11.5% 2.29† 0.87 5.99
Non-RSO drinking 700 4.0% 1
Less than once a month 1,829 8.2% 1.71† 0.96 3.06
Every month 1,222 16.3% 3.05*** 1.73 5.40
Every week 1,018 22.5% 4.30*** 2.44 7.58
Unplanned sexual intercourse
Every day or nearly 41 33.3% 5.87*** 2.46 14.00
Alcohol abstainers 386 8.1% 3.76* 1.10 12.84
Non-RSO drinking 700 1.6% 1
Less than once a month 1,829 5.5% 2.69* 1.15 6.30
Every month 1,222 8.7% 3.91** 1.68 9.09
Every week 1,018 14.3% 6.36*** 2.76 14.65
Unsafe sexual intercourse
Every day or nearly 41 15.8% 7.36*** 2.33 23.32
Alcohol abstainers 386 6.8% 1.28 0.34 4.82
Non-RSO drinking 700 3.0% 1
Less than once a month 1,829 6.2% 1.69 0.86 3.34
Every month 1,222 12.3% 3.46*** 1.78 6.72
Every week 1,018 18.8% 5.09*** 2.63 9.83
Accident or injury
Every day or nearly 41 28.1% 7.81*** 3.04 20.04
Alcohol abstainers 386 3.4% 4.40 0.61 32.05
Non-RSO drinking 700 0.5% 1
Less than once a month 1,829 2.7% 3.83† 0.91 16.06
Every month 1,222 4.1% 4.91* 1.18 20.54
Every week 1,018 8.3% 9.48** 2.30 39.04
Conflict with the police
Every day or nearly 41 12.3% 13.94*** 2.59 75.02
Alcohol abstainers 386 8.1% 2.21 0.72 6.76
Non-RSO drinking 700 3.5% 1
Less than once a month 1,829 6.4% 1.89† 0.96 3.71
Every month 1,222 10.3% 2.71** 1.39 5.29
Every week 1,018 20.1% 5.38*** 2.78 10.39
Fight
Every day or nearly 41 28.1% 12.11*** 4.91 29.91
Alcohol abstainers 386 5.4% 3.62† 0.94 13.98
Non-RSO drinking 700 2.1% 1
Less than once a month 1,829 4.4% 2.16 0.85 5.51
Every month 1,222 8.8% 4.30** 1.72 10.77
Every week 1,018 16.4% 8.90*** 3.60 22.04
Damage to somebody else's property
Every day or nearly 41 15.8% 4.48*** 1.14 17.55
1 Unlike prevalence calculations that included each participant, abstainers at follow-up were excluded from Odds Ratio calculations due to non-exposure; Odds ratios were
adjusted for smoking and parents' financial status.
† p <0.10; * p <0.05; ** p <0.01; *** p <0.001.
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Figures (large format)
Figure 1
RSOD frequency transitions from baseline (BL) to follow-up (FU) (N = 5,196).
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